Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium
M.E. Goossens*, F. Buntinx, S. Joniau, K. Ackaert, F. Ameye, I. Billiet, J. Braeckman, A. Breugelmans, J. Darras, K. Dilen, L. Goeman, E. Kellen, B. Tombal, S. van Bruwaene, B. van Cleyenbreuge, F. van der Aa, K. Vekemans, H. van Poppel, M.P. Zeegers
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium'. Together they form a unique fingerprint.